Biotechnology

NIH Director Wants To Disband DNA Advisory Committee

Published in Vaccine Weekly, June 10th, 1996

On the advice of two expert advisory groups commissioned in 1995, Dr. Harold Varmus, U.S. National Institutes of Health (NIH) director, said that it is time to dissolve the NIH's Recombinant DNA Advisory Committee and to leave the detailed analysis of gene therapy trials to agencies such as the U.S. Food and Drug Administration (FDA).

Varmus voiced his opinion at a meeting of gene therapy researchers that was held in Hilton Head, South Carolina. He said that the Recombinant DNA Advisory Committee "... did serve some function ..." in its early days, but that the committee has outlived its usefulness. The committee consists of lawyers, ethicists, public representatives...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1996-06-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry